Social Media Ideas for Big Pharma

<![CDATA[2026 Pharm Exec Top 50 Companies]]>

Biotech deals surge to record as fear of missing out grips Big Pharma

Prospect of patents expiring on lucrative drugs prompts drugmakers to hunt for next blockbuster medicines

AstraZeneca and Bristol-Myers: when Big Pharma isn’t big enough

Sheer mass helps when enlarged balance sheets allow for bigger bets on potential blockbuster drugs

Big Pharma's Future Growth Rests on Chinese Science? Expert Says: 'We Can't Ban Our Way Out of This'

SA Asks: What's the outlook for Big Pharma M&A?

<![CDATA[Pharmaceutical Executive Daily: Eli Lilly Enters $2.8 Billion Agreement to Acquire Merida Biosciences]]>

<![CDATA[ Eli Lilly to Acquire Merida Biosciences for $2.8 Billion ]]>

<![CDATA[Pharma’s New Growth Equation: Smarter Deals, Stronger Science, Rising Costs]]>

<![CDATA[Pharmaceutical Executive Daily: Nine Companies Strike Deals for MFN Pricing]]>

<![CDATA[Pharmaceutical Executive Daily: Pharm Exec Ranks Top 50 Companies of 2026]]>

<![CDATA[CSPC Pharmaceutical & AstraZeneca Form Joint Venture for Biologics Manufacturing in China]]>

<![CDATA[Pharma M&A Roundup: Oak Hill Bio Combines with RACC, Apnimed Plans $150 Million IPO, CORE Biomedicine Se...

<![CDATA[Your Questions Answered: The Biggest Pharma and Biotech Stories This Week]]>

How the machine runs

Learn how pharma companies build durable businesses through doctors, sales networks and chronic therapies, and why regulatory risks can change fortunes overnight.

<![CDATA[The Retailization of Medicare Advantage: What Costco’s Entry Means for Pharma]]>

<![CDATA[Taking a Hard Look at Pharma's Traditional Margin Model]]>

<![CDATA[Insilico Medicine Enters $2.5 Billion Alliance with Bora Pharmaceuticals ]]>

Trump wants Big Pharma to split MMR vaccine; Big Pharma thinks it's idiotic

It took just hours for the leading pharma group to reject the recommendations.

Biotech industry leaders file brief backing FDA against ‘malicious’ mifepristone challenge

A group of 61 biopharma companies, executives and investors has filed an amicus brief in support of the FDA in an ongoing case brought by Louisiana meant to remove access to the ab...

<![CDATA[Pharmaceutical Executive Daily: DualityBio and Teva Strike Major Biopharma Deals]]>

<![CDATA[Pharmaceutical Executive Daily: Moonwalk Biosciences' $70 Million Series B]]>

<![CDATA[Amazon Pharmacy Launches GLP-1 Delivery Service ]]>

<![CDATA[Beyond the Megamerger: How Rumored AstraZeneca–BMS Discussions Signal a New Era of Pharmaceutical Competitio...

Pharma Looks to Cash in on Psychedelics as Patients Seek Alternatives to Psychotropic Drugs for Depression

Eli Lilly’s multibillion-dollar acquisition of a company that makes experimental psychedelic therapies marks the largest investment yet by a drugmaker in psychedelic medicine as a...